The one-of-a-kind solution eases the financial burden of skin substitute purchasing and reimbursement practices for Providers in all post acute markets.

TAMPA, FL, March 08, 2021 /24-7PressRelease/ — Leading wound care management and business services provider, WoundGenex, has announced the addition of Jeff Kingery as Chief Clinical Officer. Kingery, an industry veteran with more than two decades of deep clinical and operational wound care experience at organizations like RestorixHealth, Net Health and Hillrom Inc., joined WoundGenex to help construct and oversee the company’s new Premier Graft Purchasing Program. He’ll also help lead WoundGenex’s full suite of advanced wound care services and revenue cycle solutions that the brand delivers in hospital outpatient departments, private practice nursing homes, assisted living and home care settings.

“The industry continues to shift and finding a balance between optimal clinical outcomes and meeting payment criteria is often difficult,” said Kingery. “Utilizing advanced wound care products like skin substitutes can be an expensive investment and often reimbursement does not materialize as expected. Providers struggle with placement criteria, understanding patient benefits and the required documentation to successfully navigate payment pathways. I am excited to help WoundGenex offer a unique solution that addresses both the clinical and the financial concerns.”

The WoundGenex Premier Graft Purchasing Program leverages vendor relationships to provide its clients direct access to industry-leading cellular tissue based products (CTP) and provides member assistance navigating the reimbursement process to generate actual ROI. Premier Graft Program members tap into group purchasing power that allows WoundGenex to facilitate graft ordering at no upfront cost. Program Liaisons work with client’s staff and billing specialists to help take the guesswork out of everything from proper utilization of product, documentation of medical necessity, coding education, and more. No payment is due until the Provider is reimbursed on the graft.

WoundGenex launched the program in 2020 and despite the myriad impacts of the Covid 19 pandemic, many clinicians have already enrolled and are utilizing the program. As the industry starts to adjust to the “new normal” the program has gained momentum. WoundGenex will now launch the Premier Graft Program nationwide, focusing on wound care providers in all settings, including private offices and hospitals.

About WoundGenex
Founded in Tampa, FL in 2014, WoundGenex optimizes the way hospitals, surgery centers, and physician practices provide wound care to their patients. Thanks to more than two decades of experience in both the clinical and administrative aspects of wound care, WoundGenex provides true solutions to help meet the challenges of providing best-in-class care from start to finish – from clinical and operational excellence to financial and procedural optimization. WoundGenex is the creator of the Premier Graft Purchasing Program, delivering graft purchasing and reimbursement power back to healthcare providers.

To learn more about WoundGenex and the Premier Graft Purchasing Program, please visit the WoundGenex website, call us at 888.539.4542, or email us at [email protected].

Contact: WoundGenex Marketing Department

For the original version of this press release, please visit here